Lord, Abbett & Co’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-214,901
Closed -$12.7M 627
2021
Q4
$12.7M Sell
214,901
-2,086
-1% -$144K 0.03% 455
2021
Q3
$14.4M Sell
216,987
-133,128
-38% -$8.21M 0.03% 460
2021
Q2
$22.1M Sell
350,115
-34,620
-9% -$1.95M 0.05% 402
2021
Q1
$20M Buy
384,735
+43,324
+13% +$2.63M 0.05% 421
2020
Q4
$15M Buy
341,411
+96,795
+40% +$4.61M 0.04% 458
2020
Q3
$11.6M Buy
244,616
+62,282
+34% +$2.52M 0.04% 450
2020
Q2
$5.52M Buy
+182,334
New +$4.06M 0.02% 563

Other funds holding CYRX

Lord, Abbett & Co's CYRX Position: Q1 2022 in Review

Lord, Abbett & Co sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 214,901 shares — an estimated $12.7M sold.

Lord, Abbett & Co first reported a position in CYRX in Q2 2020 and held it in 7 quarters. The position peaked at $22.1M in Q2 2021. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.

  • Lord, Abbett & Co reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 214,901 CryoPort shares in Q1 2022, an estimated $12.7M.
  • Lord, Abbett & Co first reported a position in CryoPort in Q2 2020 and held it in 7 quarters.
  • Lord, Abbett & Co's CryoPort position peaked at $22.1M in Q2 2021.
  • 200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.

Based on Lord, Abbett & Co's 13F filing for Q1 2022, filed 13 May 2022.